Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Empagliflozin (10mg) + Linagliptin (5mg)
Dosage Form : Tablet
Packaging Type :
Packaging :
Price : ₹1/-
Emplozin L 10/5 Tablet is a combination therapy containing Empagliflozin (10mg) and Linagliptin (5mg), designed to provide effective management of type 2 diabetes mellitus. This combination works through complementary mechanisms to help control blood sugar levels and improve overall glycemic control in diabetic patients.
Together, these two drugs target different pathways to manage type 2 diabetes, providing a balanced and effective solution for maintaining blood sugar levels within a healthy range.
Common side effects may include nasopharyngitis, headache, urinary tract infections, and gastrointestinal disturbances. Serious side effects can include dehydration, hypotension, or kidney problems.
Emplozin L 10/5 Tablet is indicated for the management of type 2 diabetes mellitus to improve glycemic control, especially in patients who are unable to achieve adequate control through diet, exercise, and other medications alone.
Consult your doctor before using if you have a history of kidney problems or urinary tract infections. Do not use if pregnant or breastfeeding.
Composition : Bromfenac (0.09% w/v) + Moxifloxacin (0.5% w/v)
Composition : Bromfenac (0.9mg)
Composition : Carboxymethylcellulose (3mg/ml) + Glycerin (10mg/ml) + n-acetylcarnosine (10mg/ml)
Composition : Dexamethasone (0.1% w/v) + Tobramycin (0.3% w/v)
Composition : Fluconazole (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
Composition : Ketorolac (0.4% w/v) + Olopatadine (0.1% w/v)
Composition : Ketorolac (0.5% w/v)
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
Composition : Loteprednol etabonate (0.5% w/v)